Skip to main content
Clinical Trials/JPRN-UMIN000044374
JPRN-UMIN000044374Completed未知

A prospective study examining the effect of brolcizumab on neovascular age-related macular degeneration in Japanese with treat and extend - A prospective stud ; brolcizumab on nAMD in Japanese with treat and extend

Jichi Medical University0 sites50 target enrollmentStarted: May 31, 2021Last updated:

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
50years-old to 89years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Eye surgery within 3 months There are other disorders that cause vision loss History of vitreous surgery History of grid-like photocoagulation History of cerebrocardiovascular events within 6 months Adults who are judged to lack informed consent Doctor judges that it is not suitable for this study

Investigators

Similar Trials

A study examining the effect of the... | Clinical Trial